Regional Analysis

Global Animal Biotechnology Market- Regional Insights

North America is expected to be the largest market for animal biotechnology during the forecast period, accounting for over 35.7% of the market share in 2023. North America has established itself as the dominant player in the global animal biotechnology market over the years. The region has the strongest market presence with leading global players having their headquarters based out of the U.S. and Canada. Major animal biotech companies like Monsanto, DuPont, and Elanco have invested heavily in R&D in the region, establishing world-class research facilities and laboratories. This focus on innovation and technology development has driven advancements in animal genetics, stem cell research, and animal health management products.

Furthermore, the positive regulatory environment and funding support for biotechnology from the government bodies like the U.S. Food and Drug Administration (FDA) and United States Department of Agriculture (USDA) has encouraged growth. Farmers and producers in the region have also readily adopted new animal biotech solutions. For instance, growth hormones, genetically modified feed, and vaccines developed using genetic engineering techniques see extensive adoption amongst the large industrial livestock farms in North America. The region also dominates international trade with significant exports of advanced animal diagnostic equipment, genetically engineered animal semen, and embryos to markets across the world.

Asia Pacific is expected to be the second-largest market for animal biotechnology, accounting for over 25.2% of the market share in 2023. Asia Pacific is witnessing the fastest expansion, led by China and India. These nations have a massive livestock population and growing meat consumption has raised the demand for animal protein. This has prompted increased focus on factors like animal health, production efficiency, and quality standards. Both the governments and private players in countries like China are investing heavily to modernize the livestock industry using biotechnology solutions. For instance, Chinese companies are actively collaborating with global diagnostic majors for the development and localization of new tests and vaccines.

Additionally, rising affluence is driving the demand for superior animal products like hormone-free milk in the region. Local producers are keen to adopt productivity-enhancing solutions to meet these evolving needs and gain access to international markets. Furthermore, impetus comes from rising R&D budgets and growing expertise in genetic engineering within educational institutes in the region. This positions Asia Pacific favorably as the next frontier for notable developments in this field.

Europe is expected to be the fastest-growing market for animal biotechnology, with a share of 19% during the forecast period. The growth of the market in Europe is attributed to the increasing prevalence of zoonotic disease in the region.